Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.
Where this comes from
- Record sourced from PubMed, PMID 37084734.
- Also identified by DOI 10.1016/j.xcrm.2023.101021 and PMC identifier 10213803.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Swen et al.<sup>1</sup> examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care.
Medical subject headings
- Pharmacogenetics
- Drug-Related Side Effects and Adverse Reactions